SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 187 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $89,000 | -50.3% | 18,145 | -58.5% | 0.00% | -100.0% |
| Q2 2022 | $179,000 | -44.1% | 43,745 | -20.7% | 0.00% | 0.0% |
| Q1 2022 | $320,000 | -32.6% | 55,145 | -12.8% | 0.00% | -50.0% |
| Q4 2021 | $475,000 | -18.9% | 63,270 | -2.8% | 0.00% | -33.3% |
| Q3 2021 | $586,000 | +581.4% | 65,070 | +529.7% | 0.00% | +200.0% |
| Q4 2019 | $86,000 | -8.5% | 10,333 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $94,000 | -16.1% | 10,333 | -0.4% | 0.00% | 0.0% |
| Q2 2019 | $112,000 | +7.7% | 10,378 | -5.0% | 0.00% | 0.0% |
| Q1 2019 | $104,000 | -18.1% | 10,928 | -0.9% | 0.00% | 0.0% |
| Q4 2018 | $127,000 | -32.1% | 11,028 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $187,000 | +19.1% | 11,028 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $157,000 | -25.9% | 11,028 | -1.3% | 0.00% | 0.0% |
| Q1 2018 | $212,000 | +12.2% | 11,178 | -3.0% | 0.00% | 0.0% |
| Q4 2017 | $189,000 | +9.2% | 11,528 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $173,000 | +68.0% | 11,528 | -1.3% | 0.00% | +100.0% |
| Q2 2017 | $103,000 | +68.9% | 11,678 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $61,000 | +69.4% | 11,678 | -0.8% | 0.00% | 0.0% |
| Q4 2016 | $36,000 | -43.8% | 11,778 | -14.2% | 0.00% | 0.0% |
| Q3 2016 | $64,000 | -62.8% | 13,728 | -53.6% | 0.00% | -75.0% |
| Q2 2016 | $172,000 | +81.1% | 29,556 | +88.5% | 0.00% | +100.0% |
| Q1 2016 | $95,000 | -31.7% | 15,678 | +3.3% | 0.00% | -50.0% |
| Q4 2015 | $139,000 | +65.5% | 15,178 | +1.3% | 0.00% | +100.0% |
| Q3 2015 | $84,000 | -99.9% | 14,978 | -0.5% | 0.00% | -33.3% |
| Q2 2015 | $166,905,000 | +68303.7% | 15,050 | -3.2% | 0.00% | -40.0% |
| Q1 2015 | $244,000 | -99.9% | 15,550 | -6.0% | 0.01% | 0.0% |
| Q4 2014 | $251,726,000 | +45.4% | 16,550 | +3.1% | 0.01% | +25.0% |
| Q3 2014 | $173,099,000 | -27.1% | 16,050 | +3.2% | 0.00% | -20.0% |
| Q2 2014 | $237,449,000 | -9.1% | 15,550 | +7.6% | 0.01% | -16.7% |
| Q1 2014 | $261,256,000 | +30.2% | 14,450 | 0.0% | 0.01% | +20.0% |
| Q4 2013 | $200,711,000 | +32.4% | 14,450 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $151,581,000 | – | 14,450 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |